During the forecast period 2023 to 2033, the Cellulitis Management Market is expected to grow at a value of 11.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Cellulitis management is expected to rise up to a market valuation of US$ 3.7 Billion. Growth of the market can be …
Monthly Archives: September 2023
Empathy and Economics Collide: Pet Cancer Therapeutics Market to Reach US$ 1052.80 Billion by 2033
The Pet Cancer Therapeutics Market refers to the pharmaceuticals and treatment options available for pets diagnosed with cancer. It encompasses a range of therapies, including chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions, among others. The market for pet cancer therapeutics has been growing in recent years due to several factors. Firstly, there has …
Triptorelin Market Riding High On Wave of Endocrine Disorder Epidemic, Forecast To Grow At 5% CAGR Through 2033
In 2023, it is anticipated that the Triptorelin Market will be worth roughly US$ 955.50 million. From 2023 to 2033, the industry is expected to grow at a 5% CAGR, driven by the increased prevalence of endometriosis among females around the world. The triptorelin market is anticipated to produce US$ 1556.41 million by 2033. Salivary …
Surface Disinfectants Market on Course to Reach a US$ 16.4 Billion Benchmark by 2033
In 2023, the surface disinfectants market is anticipated to be worth US$ 8.1 billion. Over the following ten years, the market for surface disinfectants is anticipated to exceed US$ 16.4 billion, according to Future Market Insights (FMI). Between 2023 and 2033, the market is anticipated to grow at a CAGR of 7.3%. Leading manufacturers of …
Hyperinsulinemia Hypoglycaemia Treatment Market is anticipated to reach US$ 179.08 Million by 2033, growing at a CAGR of 6% from 2023 to 2033
According to FMI, the Hyperinsulinemia Hypoglycaemia Treatment Market is foreseen to rise to US$ 100 million in FY 2023, representing a Y-o-Y increase of over 4%. Across the forecast period ranging from 2023 to 2033, the industry is likely to gain traction at a CAGR of 6%, reaching a market value of US$ 179.08 million …
Nurse Call Systems Market Anticipates Surpassing US$ 4.55 Billion by 2033
The nurse call Systems market is anticipated to expand at a consistent CAGR of 8.8% over the course of the forecast period. The market is currently valued at US$ 1.96 billion, and by 2033, it is anticipated to reach US$ 4.55 billion. The high penetration of digitization in healthcare facilities is contributing to the sales …
Continue reading “Nurse Call Systems Market Anticipates Surpassing US$ 4.55 Billion by 2033”
Enteral Feeding Devices Market Set to Exceed the US$ 4.1 Billion Milestone by 2033
The enteral feeding devices market is anticipated to expand at a 4.0% CAGR over the course of the forecast period. By 2023, the market is projected to be worth US$ 2.8 billion, and by 2033, it will be worth US$ 4.1 billion. A recent market report by Future Market Insights (FMI) predicts that between 2020 …
Predictive Disease Analytics Market: Empowering Healthcare Providers to Revolutionize Patient Care With 22.5% CAGR Growth | FMI
The global Predictive Disease Analytics Market is predicted to register a CAGR of 22.5% over the forecast period, as per FMI’s analysis. The industry’s size is anticipated to increase from US$ 2.45 billion in 2023 to US$ 18.64 billion by 2033 end. The demand for predictive disease analytics is expected to increase owing to the …
Medical Hyperspectral Imaging Market Forecasted to Illuminate Beyond US$ 294.7 Million by 2030
By the end of 2030, the medical hyperspectral imaging market is anticipated to have grown at a 6.2% CAGR, from US$ 181.8 million in 2022 to US$ 294.7 million. Growing number of healthcare ailments continues to drive advancements in medical imaging landscape. As such, computational power, image analysis, and hyperspectral cameras are the technological innovations …
Growing Prevalence Of Neurological And Chronic Pain Conditions Fueling Demand For Gabapentin Market To US$ 3.54 Billion By 2033 | FMI
The Gabapentin Market is capturing a valuation of US$ 2.11 billion in 2023 and is predicted to reach US$ 3.54 billion by 2033. The market is registering a CAGR of 5.3% during the forecast period. The Gabapentin market has witnessed significant growth in recent years, driven by its expanding range of medical applications and increasing recognition as …